ResApp’s Confirmatory Study Fails, Resulting in Pfizer’s Lower A$0.146 Offer
The revised SID provides no obvious way for Pfizer to pull its offer. At the last close of A$0.125, the gross spread to the unconfirmed data offer price of A$0.146 is 16.8%.